CBUS · Healthcare · $118M
$1.55+5.44%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 326 Biotechnology peers
Quarterly Revenue Growth
“이번 분기 매출은 99만 달러로 전 분기 200만 달러에서 줄었지만, 상반기 매출은 270만 달러로 1년 전보다 35% 늘었어요.”
In the company's words · 2026 2분기 earnings call